Ceforanide
From Wikipedia, the free encyclopedia
|
Ceforanide
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[2-[2-(aminomethyl)phenyl]acetyl]amino}-3- {[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H21N7O6S2 |
| Mol. mass | 519.556 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 80.6% |
| Metabolism | Nil |
| Half life | 2.6 to 2.98 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Intramuscular |
Ceforanide is a second-generation cephalosporin antibiotic.
[edit] External links
- Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages.". Tubercle 69 (1): 15–25. doi:. PMID 3140456.
- Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.". Drugs 34 (4): 411–37. PMID 3315624.
- Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide.". Arch Otolaryngol Head Neck Surg 113 (4): 374–6. PMID 3814386.
|
||||||||||||||||||||

